The Moneybeat crew catches up with the latest news out of Valeant Pharmaceuticals, as its board sees a huge shakeup amid waves of controversy and a plunging stock price.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
